CD73/NT5E is a Potential Biomarker for Cancer Prognosis and Immunotherapy for Multiple Types of Cancers-Reference-Cited by-同舟云学术

CD73/NT5E is a Potential Biomarker for Cancer Prognosis and Immunotherapy for Multiple Types of Cancers

Published:2022-12-08 Issue:2 Volume:7 Page:2200263
ISSN:2701-0198
Container-title:Advanced Biology
language:en
Short-container-title:Advanced Biology

Author:

Li Huisheng¹,Xie Peng²,Li Ping¹,Du Yuheng¹,Zhu Jiajia¹,Yuan Yudong²,Wu Chao³,Shi Yantao⁴,Huang Zhiyong⁵,Wang Xudong¹,Liu Dongying⁶,Liu Weishuai⁶^ORCID

Affiliation:

1. Department of Maxillofacial & Otorhinolaryngology Cancer Tianjin Medical University Cancer Institute and Hospital National Clinical Research Center for Cancer Key Laboratory of Cancer Prevention and Therapy Tianjin's Clinical Research Center for Cancer Huanhu West Road, Hexi District Tianjin 300060 China

2. Department of Senior Ward Tianjin Medical University Cancer Institute and Hospital National Clinical Research Center for Cancer Key Laboratory of Cancer Prevention and Therapy Tianjin's Clinical Research Center for Cancer Huanhu West Road, Hexi District Tianjin 300060 China

3. Department of Pancreatic Cancer Tianjin Medical University Cancer Institute and Hospital National Clinical Research Center for Cancer Key Laboratory of Cancer Prevention and Therapy Tianjin's Clinical Research Center for Cancer Huanhu West Road, Hexi District Tianjin 300060 China

4. Department of Technology, Swanshine (Tianjin) Biotechnology Development Co. Ltd Anime East Road, Airport Economic Zone Tianjin 300308 China

5. Department of Industrial Biosystems and Bioprocessing Engineering Tianjin Institute of Industrial Biotechnology Chinese Academy of Sciences Xiqi Road Airport Economic Zone Tianjin 300308 China

6. Department of Pain Management Tianjin Medical University Cancer Institute and Hospital National Clinical Research Center for Cancer Key Laboratory of Cancer Prevention and Therapy Tianjin's Clinical Research Center for Cancer Huanhu West Road, Hexi District Tianjin 300060 China

Publisher

Wiley

Subject

General Biochemistry, Genetics and Molecular Biology,Biomedical Engineering,Biomaterials

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adbi.202200263

Reference49 articles.

1. Cancer statistics, 2022

2. Cancer treatment and survivorship statistics, 2022

3. Top 10 Challenges in Cancer Immunotherapy

4. Cell type- and tissue-specific functions of ecto-5′-nucleotidase (CD73)

5. Clinical significance of CD73 in triple-negative breast cancer: multiplex analysis of a phase III clinical trial

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integration of multiomics analyses reveals unique insights into CD24-mediated immunosuppressive tumor microenvironment of breast cancer;Inflammation Research;2024-04-15

2. Biomimetic Nanomedicine Targeting Orchestrated Metabolism Coupled with Regulatory Factors to Disrupt the Metabolic Plasticity of Breast Cancer;ACS Nano;2024-01-26

3. The Clinical Significance of CD73 in Cancer;International Journal of Molecular Sciences;2023-07-21